Global Medical Topical Hemostatic Agent Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Page: 125
Published Date: 13 Jan 2025
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Medical Topical Hemostatic Agent market size was valued at US$ 9208 million in 2024 and is forecast to a readjusted size of USD 14650 million by 2031 with a CAGR of 6.9% during review period.
Medical topical hemostatic agent are used in the setting of surgery or trauma as adjuncts to maintain hemostasis. Topical hemostat products include gelatin sponges, collagens, fibrin sealants, and active thrombin preparations. These agents are applied locally to stop blood flow.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Medical Topical Hemostatic Agent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Topical Hemostatic Agent market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Medical Topical Hemostatic Agent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Medical Topical Hemostatic Agent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Medical Topical Hemostatic Agent market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Topical Hemostatic Agent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Topical Hemostatic Agent market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Topical Hemostatic Agent market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Market segment by Application
Hospitals
Surgical Centers
Nursing Homes
Major players covered
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Topical Hemostatic Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Topical Hemostatic Agent, with price, sales quantity, revenue, and global market share of Medical Topical Hemostatic Agent from 2020 to 2025.
Chapter 3, the Medical Topical Hemostatic Agent competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Topical Hemostatic Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Medical Topical Hemostatic Agent market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Topical Hemostatic Agent.
Chapter 14 and 15, to describe Medical Topical Hemostatic Agent sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Medical Topical Hemostatic Agent Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Gelation Sponge
1.3.3 Oxidized Regenerated Cellulose Based Hemostats
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Medical Topical Hemostatic Agent Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Surgical Centers
1.4.4 Nursing Homes
1.5 Global Medical Topical Hemostatic Agent Market Size & Forecast
1.5.1 Global Medical Topical Hemostatic Agent Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Medical Topical Hemostatic Agent Sales Quantity (2020-2031)
1.5.3 Global Medical Topical Hemostatic Agent Average Price (2020-2031)
2.1 Ethicon
2.1.1 Ethicon Details
2.1.2 Ethicon Major Business
2.1.3 Ethicon Medical Topical Hemostatic Agent Product and Services
2.1.4 Ethicon Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Ethicon Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Medical Topical Hemostatic Agent Product and Services
2.2.4 Pfizer Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Pfizer Recent Developments/Updates
2.3 Baxter International
2.3.1 Baxter International Details
2.3.2 Baxter International Major Business
2.3.3 Baxter International Medical Topical Hemostatic Agent Product and Services
2.3.4 Baxter International Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Baxter International Recent Developments/Updates
2.4 C. R. Bard
2.4.1 C. R. Bard Details
2.4.2 C. R. Bard Major Business
2.4.3 C. R. Bard Medical Topical Hemostatic Agent Product and Services
2.4.4 C. R. Bard Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 C. R. Bard Recent Developments/Updates
2.5 The Medicines Company
2.5.1 The Medicines Company Details
2.5.2 The Medicines Company Major Business
2.5.3 The Medicines Company Medical Topical Hemostatic Agent Product and Services
2.5.4 The Medicines Company Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 The Medicines Company Recent Developments/Updates
2.6 Anika Therapeutics
2.6.1 Anika Therapeutics Details
2.6.2 Anika Therapeutics Major Business
2.6.3 Anika Therapeutics Medical Topical Hemostatic Agent Product and Services
2.6.4 Anika Therapeutics Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Anika Therapeutics Recent Developments/Updates
2.7 Advanced Medical Solutions
2.7.1 Advanced Medical Solutions Details
2.7.2 Advanced Medical Solutions Major Business
2.7.3 Advanced Medical Solutions Medical Topical Hemostatic Agent Product and Services
2.7.4 Advanced Medical Solutions Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Advanced Medical Solutions Recent Developments/Updates
2.8 Integra LifeSciences
2.8.1 Integra LifeSciences Details
2.8.2 Integra LifeSciences Major Business
2.8.3 Integra LifeSciences Medical Topical Hemostatic Agent Product and Services
2.8.4 Integra LifeSciences Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Integra LifeSciences Recent Developments/Updates
2.9 B Braun Melsungen
2.9.1 B Braun Melsungen Details
2.9.2 B Braun Melsungen Major Business
2.9.3 B Braun Melsungen Medical Topical Hemostatic Agent Product and Services
2.9.4 B Braun Melsungen Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 B Braun Melsungen Recent Developments/Updates
2.10 Gelita Medical
2.10.1 Gelita Medical Details
2.10.2 Gelita Medical Major Business
2.10.3 Gelita Medical Medical Topical Hemostatic Agent Product and Services
2.10.4 Gelita Medical Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Gelita Medical Recent Developments/Updates
2.11 Equimedical
2.11.1 Equimedical Details
2.11.2 Equimedical Major Business
2.11.3 Equimedical Medical Topical Hemostatic Agent Product and Services
2.11.4 Equimedical Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Equimedical Recent Developments/Updates
2.12 Vascular Solutions
2.12.1 Vascular Solutions Details
2.12.2 Vascular Solutions Major Business
2.12.3 Vascular Solutions Medical Topical Hemostatic Agent Product and Services
2.12.4 Vascular Solutions Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Vascular Solutions Recent Developments/Updates
2.13 Marine Polymer Technologies
2.13.1 Marine Polymer Technologies Details
2.13.2 Marine Polymer Technologies Major Business
2.13.3 Marine Polymer Technologies Medical Topical Hemostatic Agent Product and Services
2.13.4 Marine Polymer Technologies Medical Topical Hemostatic Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Marine Polymer Technologies Recent Developments/Updates
3.1 Global Medical Topical Hemostatic Agent Sales Quantity by Manufacturer (2020-2025)
3.2 Global Medical Topical Hemostatic Agent Revenue by Manufacturer (2020-2025)
3.3 Global Medical Topical Hemostatic Agent Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Medical Topical Hemostatic Agent by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Medical Topical Hemostatic Agent Manufacturer Market Share in 2024
3.4.3 Top 6 Medical Topical Hemostatic Agent Manufacturer Market Share in 2024
3.5 Medical Topical Hemostatic Agent Market: Overall Company Footprint Analysis
3.5.1 Medical Topical Hemostatic Agent Market: Region Footprint
3.5.2 Medical Topical Hemostatic Agent Market: Company Product Type Footprint
3.5.3 Medical Topical Hemostatic Agent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Medical Topical Hemostatic Agent Market Size by Region
4.1.1 Global Medical Topical Hemostatic Agent Sales Quantity by Region (2020-2031)
4.1.2 Global Medical Topical Hemostatic Agent Consumption Value by Region (2020-2031)
4.1.3 Global Medical Topical Hemostatic Agent Average Price by Region (2020-2031)
4.2 North America Medical Topical Hemostatic Agent Consumption Value (2020-2031)
4.3 Europe Medical Topical Hemostatic Agent Consumption Value (2020-2031)
4.4 Asia-Pacific Medical Topical Hemostatic Agent Consumption Value (2020-2031)
4.5 South America Medical Topical Hemostatic Agent Consumption Value (2020-2031)
4.6 Middle East & Africa Medical Topical Hemostatic Agent Consumption Value (2020-2031)
5.1 Global Medical Topical Hemostatic Agent Sales Quantity by Type (2020-2031)
5.2 Global Medical Topical Hemostatic Agent Consumption Value by Type (2020-2031)
5.3 Global Medical Topical Hemostatic Agent Average Price by Type (2020-2031)
6.1 Global Medical Topical Hemostatic Agent Sales Quantity by Application (2020-2031)
6.2 Global Medical Topical Hemostatic Agent Consumption Value by Application (2020-2031)
6.3 Global Medical Topical Hemostatic Agent Average Price by Application (2020-2031)
7.1 North America Medical Topical Hemostatic Agent Sales Quantity by Type (2020-2031)
7.2 North America Medical Topical Hemostatic Agent Sales Quantity by Application (2020-2031)
7.3 North America Medical Topical Hemostatic Agent Market Size by Country
7.3.1 North America Medical Topical Hemostatic Agent Sales Quantity by Country (2020-2031)
7.3.2 North America Medical Topical Hemostatic Agent Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8.1 Europe Medical Topical Hemostatic Agent Sales Quantity by Type (2020-2031)
8.2 Europe Medical Topical Hemostatic Agent Sales Quantity by Application (2020-2031)
8.3 Europe Medical Topical Hemostatic Agent Market Size by Country
8.3.1 Europe Medical Topical Hemostatic Agent Sales Quantity by Country (2020-2031)
8.3.2 Europe Medical Topical Hemostatic Agent Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9.1 Asia-Pacific Medical Topical Hemostatic Agent Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Medical Topical Hemostatic Agent Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Medical Topical Hemostatic Agent Market Size by Region
9.3.1 Asia-Pacific Medical Topical Hemostatic Agent Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Medical Topical Hemostatic Agent Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10.1 South America Medical Topical Hemostatic Agent Sales Quantity by Type (2020-2031)
10.2 South America Medical Topical Hemostatic Agent Sales Quantity by Application (2020-2031)
10.3 South America Medical Topical Hemostatic Agent Market Size by Country
10.3.1 South America Medical Topical Hemostatic Agent Sales Quantity by Country (2020-2031)
10.3.2 South America Medical Topical Hemostatic Agent Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11.1 Middle East & Africa Medical Topical Hemostatic Agent Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Medical Topical Hemostatic Agent Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Medical Topical Hemostatic Agent Market Size by Country
11.3.1 Middle East & Africa Medical Topical Hemostatic Agent Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Medical Topical Hemostatic Agent Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12.1 Medical Topical Hemostatic Agent Market Drivers
12.2 Medical Topical Hemostatic Agent Market Restraints
12.3 Medical Topical Hemostatic Agent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Medical Topical Hemostatic Agent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medical Topical Hemostatic Agent
13.3 Medical Topical Hemostatic Agent Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medical Topical Hemostatic Agent Typical Distributors
14.3 Medical Topical Hemostatic Agent Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Medical Topical Hemostatic Agent Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Medical Topical Hemostatic Agent Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Ethicon Basic Information, Manufacturing Base and Competitors
Table 4. Ethicon Major Business
Table 5. Ethicon Medical Topical Hemostatic Agent Product and Services
Table 6. Ethicon Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Ethicon Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Medical Topical Hemostatic Agent Product and Services
Table 11. Pfizer Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Pfizer Recent Developments/Updates
Table 13. Baxter International Basic Information, Manufacturing Base and Competitors
Table 14. Baxter International Major Business
Table 15. Baxter International Medical Topical Hemostatic Agent Product and Services
Table 16. Baxter International Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Baxter International Recent Developments/Updates
Table 18. C. R. Bard Basic Information, Manufacturing Base and Competitors
Table 19. C. R. Bard Major Business
Table 20. C. R. Bard Medical Topical Hemostatic Agent Product and Services
Table 21. C. R. Bard Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. C. R. Bard Recent Developments/Updates
Table 23. The Medicines Company Basic Information, Manufacturing Base and Competitors
Table 24. The Medicines Company Major Business
Table 25. The Medicines Company Medical Topical Hemostatic Agent Product and Services
Table 26. The Medicines Company Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. The Medicines Company Recent Developments/Updates
Table 28. Anika Therapeutics Basic Information, Manufacturing Base and Competitors
Table 29. Anika Therapeutics Major Business
Table 30. Anika Therapeutics Medical Topical Hemostatic Agent Product and Services
Table 31. Anika Therapeutics Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Anika Therapeutics Recent Developments/Updates
Table 33. Advanced Medical Solutions Basic Information, Manufacturing Base and Competitors
Table 34. Advanced Medical Solutions Major Business
Table 35. Advanced Medical Solutions Medical Topical Hemostatic Agent Product and Services
Table 36. Advanced Medical Solutions Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Advanced Medical Solutions Recent Developments/Updates
Table 38. Integra LifeSciences Basic Information, Manufacturing Base and Competitors
Table 39. Integra LifeSciences Major Business
Table 40. Integra LifeSciences Medical Topical Hemostatic Agent Product and Services
Table 41. Integra LifeSciences Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Integra LifeSciences Recent Developments/Updates
Table 43. B Braun Melsungen Basic Information, Manufacturing Base and Competitors
Table 44. B Braun Melsungen Major Business
Table 45. B Braun Melsungen Medical Topical Hemostatic Agent Product and Services
Table 46. B Braun Melsungen Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. B Braun Melsungen Recent Developments/Updates
Table 48. Gelita Medical Basic Information, Manufacturing Base and Competitors
Table 49. Gelita Medical Major Business
Table 50. Gelita Medical Medical Topical Hemostatic Agent Product and Services
Table 51. Gelita Medical Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Gelita Medical Recent Developments/Updates
Table 53. Equimedical Basic Information, Manufacturing Base and Competitors
Table 54. Equimedical Major Business
Table 55. Equimedical Medical Topical Hemostatic Agent Product and Services
Table 56. Equimedical Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Equimedical Recent Developments/Updates
Table 58. Vascular Solutions Basic Information, Manufacturing Base and Competitors
Table 59. Vascular Solutions Major Business
Table 60. Vascular Solutions Medical Topical Hemostatic Agent Product and Services
Table 61. Vascular Solutions Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Vascular Solutions Recent Developments/Updates
Table 63. Marine Polymer Technologies Basic Information, Manufacturing Base and Competitors
Table 64. Marine Polymer Technologies Major Business
Table 65. Marine Polymer Technologies Medical Topical Hemostatic Agent Product and Services
Table 66. Marine Polymer Technologies Medical Topical Hemostatic Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Marine Polymer Technologies Recent Developments/Updates
Table 68. Global Medical Topical Hemostatic Agent Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 69. Global Medical Topical Hemostatic Agent Revenue by Manufacturer (2020-2025) & (USD Million)
Table 70. Global Medical Topical Hemostatic Agent Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 71. Market Position of Manufacturers in Medical Topical Hemostatic Agent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 72. Head Office and Medical Topical Hemostatic Agent Production Site of Key Manufacturer
Table 73. Medical Topical Hemostatic Agent Market: Company Product Type Footprint
Table 74. Medical Topical Hemostatic Agent Market: Company Product Application Footprint
Table 75. Medical Topical Hemostatic Agent New Market Entrants and Barriers to Market Entry
Table 76. Medical Topical Hemostatic Agent Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Medical Topical Hemostatic Agent Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 78. Global Medical Topical Hemostatic Agent Sales Quantity by Region (2020-2025) & (K Units)
Table 79. Global Medical Topical Hemostatic Agent Sales Quantity by Region (2026-2031) & (K Units)
Table 80. Global Medical Topical Hemostatic Agent Consumption Value by Region (2020-2025) & (USD Million)
Table 81. Global Medical Topical Hemostatic Agent Consumption Value by Region (2026-2031) & (USD Million)
Table 82. Global Medical Topical Hemostatic Agent Average Price by Region (2020-2025) & (US$/Unit)
Table 83. Global Medical Topical Hemostatic Agent Average Price by Region (2026-2031) & (US$/Unit)
Table 84. Global Medical Topical Hemostatic Agent Sales Quantity by Type (2020-2025) & (K Units)
Table 85. Global Medical Topical Hemostatic Agent Sales Quantity by Type (2026-2031) & (K Units)
Table 86. Global Medical Topical Hemostatic Agent Consumption Value by Type (2020-2025) & (USD Million)
Table 87. Global Medical Topical Hemostatic Agent Consumption Value by Type (2026-2031) & (USD Million)
Table 88. Global Medical Topical Hemostatic Agent Average Price by Type (2020-2025) & (US$/Unit)
Table 89. Global Medical Topical Hemostatic Agent Average Price by Type (2026-2031) & (US$/Unit)
Table 90. Global Medical Topical Hemostatic Agent Sales Quantity by Application (2020-2025) & (K Units)
Table 91. Global Medical Topical Hemostatic Agent Sales Quantity by Application (2026-2031) & (K Units)
Table 92. Global Medical Topical Hemostatic Agent Consumption Value by Application (2020-2025) & (USD Million)
Table 93. Global Medical Topical Hemostatic Agent Consumption Value by Application (2026-2031) & (USD Million)
Table 94. Global Medical Topical Hemostatic Agent Average Price by Application (2020-2025) & (US$/Unit)
Table 95. Global Medical Topical Hemostatic Agent Average Price by Application (2026-2031) & (US$/Unit)
Table 96. North America Medical Topical Hemostatic Agent Sales Quantity by Type (2020-2025) & (K Units)
Table 97. North America Medical Topical Hemostatic Agent Sales Quantity by Type (2026-2031) & (K Units)
Table 98. North America Medical Topical Hemostatic Agent Sales Quantity by Application (2020-2025) & (K Units)
Table 99. North America Medical Topical Hemostatic Agent Sales Quantity by Application (2026-2031) & (K Units)
Table 100. North America Medical Topical Hemostatic Agent Sales Quantity by Country (2020-2025) & (K Units)
Table 101. North America Medical Topical Hemostatic Agent Sales Quantity by Country (2026-2031) & (K Units)
Table 102. North America Medical Topical Hemostatic Agent Consumption Value by Country (2020-2025) & (USD Million)
Table 103. North America Medical Topical Hemostatic Agent Consumption Value by Country (2026-2031) & (USD Million)
Table 104. Europe Medical Topical Hemostatic Agent Sales Quantity by Type (2020-2025) & (K Units)
Table 105. Europe Medical Topical Hemostatic Agent Sales Quantity by Type (2026-2031) & (K Units)
Table 106. Europe Medical Topical Hemostatic Agent Sales Quantity by Application (2020-2025) & (K Units)
Table 107. Europe Medical Topical Hemostatic Agent Sales Quantity by Application (2026-2031) & (K Units)
Table 108. Europe Medical Topical Hemostatic Agent Sales Quantity by Country (2020-2025) & (K Units)
Table 109. Europe Medical Topical Hemostatic Agent Sales Quantity by Country (2026-2031) & (K Units)
Table 110. Europe Medical Topical Hemostatic Agent Consumption Value by Country (2020-2025) & (USD Million)
Table 111. Europe Medical Topical Hemostatic Agent Consumption Value by Country (2026-2031) & (USD Million)
Table 112. Asia-Pacific Medical Topical Hemostatic Agent Sales Quantity by Type (2020-2025) & (K Units)
Table 113. Asia-Pacific Medical Topical Hemostatic Agent Sales Quantity by Type (2026-2031) & (K Units)
Table 114. Asia-Pacific Medical Topical Hemostatic Agent Sales Quantity by Application (2020-2025) & (K Units)
Table 115. Asia-Pacific Medical Topical Hemostatic Agent Sales Quantity by Application (2026-2031) & (K Units)
Table 116. Asia-Pacific Medical Topical Hemostatic Agent Sales Quantity by Region (2020-2025) & (K Units)
Table 117. Asia-Pacific Medical Topical Hemostatic Agent Sales Quantity by Region (2026-2031) & (K Units)
Table 118. Asia-Pacific Medical Topical Hemostatic Agent Consumption Value by Region (2020-2025) & (USD Million)
Table 119. Asia-Pacific Medical Topical Hemostatic Agent Consumption Value by Region (2026-2031) & (USD Million)
Table 120. South America Medical Topical Hemostatic Agent Sales Quantity by Type (2020-2025) & (K Units)
Table 121. South America Medical Topical Hemostatic Agent Sales Quantity by Type (2026-2031) & (K Units)
Table 122. South America Medical Topical Hemostatic Agent Sales Quantity by Application (2020-2025) & (K Units)
Table 123. South America Medical Topical Hemostatic Agent Sales Quantity by Application (2026-2031) & (K Units)
Table 124. South America Medical Topical Hemostatic Agent Sales Quantity by Country (2020-2025) & (K Units)
Table 125. South America Medical Topical Hemostatic Agent Sales Quantity by Country (2026-2031) & (K Units)
Table 126. South America Medical Topical Hemostatic Agent Consumption Value by Country (2020-2025) & (USD Million)
Table 127. South America Medical Topical Hemostatic Agent Consumption Value by Country (2026-2031) & (USD Million)
Table 128. Middle East & Africa Medical Topical Hemostatic Agent Sales Quantity by Type (2020-2025) & (K Units)
Table 129. Middle East & Africa Medical Topical Hemostatic Agent Sales Quantity by Type (2026-2031) & (K Units)
Table 130. Middle East & Africa Medical Topical Hemostatic Agent Sales Quantity by Application (2020-2025) & (K Units)
Table 131. Middle East & Africa Medical Topical Hemostatic Agent Sales Quantity by Application (2026-2031) & (K Units)
Table 132. Middle East & Africa Medical Topical Hemostatic Agent Sales Quantity by Country (2020-2025) & (K Units)
Table 133. Middle East & Africa Medical Topical Hemostatic Agent Sales Quantity by Country (2026-2031) & (K Units)
Table 134. Middle East & Africa Medical Topical Hemostatic Agent Consumption Value by Country (2020-2025) & (USD Million)
Table 135. Middle East & Africa Medical Topical Hemostatic Agent Consumption Value by Country (2026-2031) & (USD Million)
Table 136. Medical Topical Hemostatic Agent Raw Material
Table 137. Key Manufacturers of Medical Topical Hemostatic Agent Raw Materials
Table 138. Medical Topical Hemostatic Agent Typical Distributors
Table 139. Medical Topical Hemostatic Agent Typical Customers
List of Figures
Figure 1. Medical Topical Hemostatic Agent Picture
Figure 2. Global Medical Topical Hemostatic Agent Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Medical Topical Hemostatic Agent Revenue Market Share by Type in 2024
Figure 4. Gelation Sponge Examples
Figure 5. Oxidized Regenerated Cellulose Based Hemostats Examples
Figure 6. Others Examples
Figure 7. Global Medical Topical Hemostatic Agent Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Medical Topical Hemostatic Agent Revenue Market Share by Application in 2024
Figure 9. Hospitals Examples
Figure 10. Surgical Centers Examples
Figure 11. Nursing Homes Examples
Figure 12. Global Medical Topical Hemostatic Agent Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Medical Topical Hemostatic Agent Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Medical Topical Hemostatic Agent Sales Quantity (2020-2031) & (K Units)
Figure 15. Global Medical Topical Hemostatic Agent Price (2020-2031) & (US$/Unit)
Figure 16. Global Medical Topical Hemostatic Agent Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Medical Topical Hemostatic Agent Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Medical Topical Hemostatic Agent by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Medical Topical Hemostatic Agent Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Medical Topical Hemostatic Agent Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Medical Topical Hemostatic Agent Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Medical Topical Hemostatic Agent Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Medical Topical Hemostatic Agent Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Medical Topical Hemostatic Agent Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Medical Topical Hemostatic Agent Average Price by Type (2020-2031) & (US$/Unit)
Figure 31. Global Medical Topical Hemostatic Agent Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Medical Topical Hemostatic Agent Revenue Market Share by Application (2020-2031)
Figure 33. Global Medical Topical Hemostatic Agent Average Price by Application (2020-2031) & (US$/Unit)
Figure 34. North America Medical Topical Hemostatic Agent Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Medical Topical Hemostatic Agent Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Medical Topical Hemostatic Agent Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Medical Topical Hemostatic Agent Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Medical Topical Hemostatic Agent Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Medical Topical Hemostatic Agent Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Medical Topical Hemostatic Agent Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Medical Topical Hemostatic Agent Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 46. France Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Medical Topical Hemostatic Agent Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Medical Topical Hemostatic Agent Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Medical Topical Hemostatic Agent Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Medical Topical Hemostatic Agent Consumption Value Market Share by Region (2020-2031)
Figure 54. China Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 57. India Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Medical Topical Hemostatic Agent Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Medical Topical Hemostatic Agent Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Medical Topical Hemostatic Agent Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Medical Topical Hemostatic Agent Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Medical Topical Hemostatic Agent Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Medical Topical Hemostatic Agent Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Medical Topical Hemostatic Agent Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Medical Topical Hemostatic Agent Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Medical Topical Hemostatic Agent Consumption Value (2020-2031) & (USD Million)
Figure 74. Medical Topical Hemostatic Agent Market Drivers
Figure 75. Medical Topical Hemostatic Agent Market Restraints
Figure 76. Medical Topical Hemostatic Agent Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Medical Topical Hemostatic Agent in 2024
Figure 79. Manufacturing Process Analysis of Medical Topical Hemostatic Agent
Figure 80. Medical Topical Hemostatic Agent Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Ethicon Pfizer Baxter International C. R. Bard The Medicines Company Anika Therapeutics Advanced Medical Solutions Integra LifeSciences B Braun Melsungen Gelita Medical Equimedical Vascular Solutions Marine Polymer Technologies
Related Reports
07 Aug 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
